Non ST Segment Elevation Myocardial Infarction
10
1
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Distal vs. Forearm Radial Artery Access
Does OCT Optimise Results of Stenting on the Left Main Stem
OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)
One-hour Diagnostic Algorithm for NSTEMI
EKG Criteria and Identification of Acute Coronary Occlusion
Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography